XML 45 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Common stock - Restricted common stock activity (Details) - Restricted stock
9 Months Ended
Sep. 30, 2017
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Beginning balance, unvested, number of shares | shares 1,185,958
Issued, number of shares | shares 0
Vested, number of shares | shares (762,228)
Forfeited, number of shares | shares 0
Ending balance, unvested, number of shares | shares 423,730
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance, weighted average grant date fair value (in usd per share) | $ / shares $ 0.10
Issued, weighted average grant date fair value (in usd per share) | $ / shares 0.00
Vested, weighted average grant date fair value (in usd per share) | $ / shares 0.10
Forfeited, weighted average grant date fair value (in usd per share) | $ / shares 0.00
Ending balance, weighted average grant date fair value (in usd per share) | $ / shares $ 0.10
Non-employee Consultants and Advisers  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Beginning balance, unvested, number of shares | shares 10,834
Issued, number of shares | shares 0
Vested, number of shares | shares (4,125)
Forfeited, number of shares | shares 0
Ending balance, unvested, number of shares | shares 6,709
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance, weighted average grant date fair value (in usd per share) | $ / shares $ 9.72
Issued, weighted average grant date fair value (in usd per share) | $ / shares 0.00
Vested, weighted average grant date fair value (in usd per share) | $ / shares 8.95
Forfeited, weighted average grant date fair value (in usd per share) | $ / shares 0.00
Ending balance, weighted average grant date fair value (in usd per share) | $ / shares $ 10.19